Navigation Links
Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease
Date:3/27/2008

Study Highlights Growing Therapeutic Value of Cord Blood Stem Cells

OLDSMAR, Fla., March 27 /PRNewswire-FirstCall/ -- Stems cells derived from umbilical cord blood are showing early potential in fighting Alzheimer's disease, according to results from a new preclinical study published in the March issue of Stem Cells and Development. The study, conducted by researchers from the University of South Florida and Saneron CCEL Therapeutics, Inc., found that targeted immune suppression using stem cells derived from human umbilical cord blood reduced Alzheimer's disease progression in a mouse model. Alzheimer's disease is a progressive and incurable brain disease that affects more than five million people in the United States alone. The ongoing research project has been funded in part by Cryo-Cell International, Inc., an industry leader in stem cell innovation and one of the nation's largest and most established family cord blood banks. Additional study sponsors are the National Institutes of Health's STTR grant program, Florida High Tech Corridor Matching grant program, and the Johnnie B. Byrd, Sr. Alzheimer's Center and Research Institute."

An abundance of research conducted in the last two decades alone has demonstrated the life-saving potential of stem cells derived from umbilical cord blood. In fact, stem cells found in cord blood have been proven to treat more than 70 life-threatening illnesses, including leukemia, neuroblastoma, ischemic brain injury and Type 1 diabetes. Since the first successful cord blood stem cell transplant in 1988, cord blood stem cells have been used in more than 7,000 transplants. Each year, an estimated 12,000 Americans could benefit from a stem cell transplant.

"The scientific community has only skimmed the surface in uncovering the many potential therapeutic uses for cord blood stem cells, and this new research in Alzheimer's disease may pave the way for discoveries around the use of these cells for a host of ne
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
3. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies
4. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
7. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
8. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
9. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
10. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
11. Potential Early Warning System for Lung Cancer Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), ... CytoSorb® blood purification technology to help fight deadly ... 28 countries worldwide, today announced the appointment of ... FACS, as its Senior Vice President of Clinical ... Dr. Di Russo is an accomplished ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today ... a first-in-human Phase 1 clinical trial of APD597, a ... the glucose-dependent insulinotropic receptor (GDIR) for the treatment of ... Arena and has the potential to stimulate insulin release ...
... Corporation of North,America today announced that the U.S. ... disodium) Injection, an intravenous,sedative-hypnotic agent for monitored anesthesia ... therapeutic procedures. , ... LUSEDRA be used only by persons,trained in the ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 4FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 2FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 3FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 4
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 ... sex for one year will be allowed to donate blood in ... a 31-year ban on donations from men who have sex with ... intention to release a new draft guidance in early 2015 that ... The FDA is changing its policy based on data from ...
(Date:12/24/2014)... News) -- A new, injectable weight-loss drug has been ... The agency on Tuesday approved Saxenda (liraglutide) for adults ... and have at least one weight-related health condition, such ... cholesterol. Patients taking the drug, made by Novo ... regularly, the FDA noted. "Obesity is a public ...
(Date:12/24/2014)... Tara Haelle HealthDay Reporter ... Teens are more likely to start smoking or drinking ... disorder (ADHD) or conduct disorder, new research suggests. ... about the risk of substance use as [these] children ... director at Cincinnati Pediatric Research Group, which is part ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Gluten, a ... on those who have an intolerance to gluten, causing ... gas, bloating, migraine headaches, joint pain and fatigue. For ... diet plans that deliver safe and fast weight ... that trigger a gluten allergy reaction. These gluten free ...
(Date:12/24/2014)... 24, 2014 Dr. Svetlana Gomer, MGS ... the nation gathered with US Marines on November 14, ... funds for the Toys for Tots Literacy Program. ... of new books and audio books for the Toys ... children this Christmas. It represents another major strike in ...
Breaking Medicine News(10 mins):Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3
... The Johns Hopkins Bloomberg School of Public Health has awarded ... efforts to reduce polio globally as well as his work ... Democratic Republic of Congo. Mutombo will be presented with the ... Health in Baltimore, Md., on April 13. "Mr. Mutombo ...
... News) -- In most people, plaque formation in arteries occurs ... according to a new study. Researchers at the Karolinska ... surgery to remove plaque buildup in arteries in their neck. ... than the patients, who were on average 68 years old ...
... available in Spanish and French . ... a conflict arises within the couple. Conversely, it is men ... cause conflicts more frequently. This is the conclusion described ... prepared by professors from the Department of Social Psychology ...
... pregnant women, high induction and first-cesarean delivery rates do not ... published in the April issue of The Journal of ... of intervention at delivery whether high, low, or in ... new babies brings into question the skyrocketing number of both ...
... IL (April 13, 2011 ) This week at ... about dietary cholesterol intake and cardiovascular disease risk were ... variety of poster presentations. Experts from leading institutions discussed ... its association with heart disease risk, dispelling some commonly ...
... Children were the victims in more than half of the ... between 1997 and 2009, according to a new study by ... to prevent injury from the pressurized and often harsh chemical ... 0 to 4, were the most likely to be hurt ...
Cached Medicine News:Health News:Artery Plaque Forms in Short Time Span, Scientists Say 2Health News:Women have more intense emotions than men when conflict arises within the couple 2Health News:More interventions at delivery not linked to healthier newborns 2Health News:More interventions at delivery not linked to healthier newborns 3Health News:Experts at Experimental Biology examine dietary cholesterol, egg intake and heart disease risk 2Health News:Children victims of most eye injuries from aerosols 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: